Skip to main content
ADAG
NASDAQ Life Sciences

Adagene's Muzastotug Shows 31% ORR in MSS CRC, Cash Runway Extended to Late 2028

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$3.8
Mkt Cap
$184.33M
52W Low
$1.3
52W High
$4.85
52W Position info
192% above low
Off High info
22% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

ADAG has more than doubled off its 52-week low of $1.3.

Summary

Adagene reported H1 2026 results with $127.9M in cash, extending runway into late 2028. The lead asset muzastotug demonstrated a 31% confirmed ORR in MSS CRC at the 20 mg/kg dose, with median PFS of 6.7 months and OS not yet reached. A randomized Phase 2 trial is enrolling, with results expected in 1H 2027, and a potential registration trial could start in 2027. Dosing has begun in a global Phase 1/2 basket trial with a Sanofi next-gen IO agent. The data strengthens muzastotug's profile as a backbone therapy, and the cash position supports pipeline acceleration.

At the time of this announcement, ADAG was trading at $3.80 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $184.3M. The 52-week trading range was $1.30 to $4.85. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

ADAG - Latest Insights

ADAG
Nov 17, 2026, 8:00 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.60
Real-time Price: $1.87 info
Change: +$0.270 (+17%) info
Market Cap: $134.958M info
ADAG
Nov 09, 2026, 7:00 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $2.00
Real-time Price: $1.87 info
Change: -$0.130 (-6%) info
Market Cap: $134.958M info
ADAG
Nov 09, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.00
Real-time Price: $1.87 info
Change: -$0.130 (-6%) info
Market Cap: $134.958M info
ADAG
Sep 22, 2026, 8:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $3.21
Real-time Price: $1.87 info
Change: -$1.34 (-42%) info
Market Cap: $134.958M info
ADAG
Sep 22, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.21
Real-time Price: $1.87 info
Change: -$1.34 (-42%) info
Market Cap: $134.958M info